1-6 of 6
Gautam Sajeev
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retrospective Real-World Analysis of Survival Outcomes in Patients with Myelofibrosis and New or Worsening Anemia Treated with Ruxolitinib in the United States

Andrew T. Kuykendall, Francesca Palandri, Shiyuan Zhang, Tom Liu, Mirko Fillbrunn, Adina Zhang, Gautam Sajeev, James Signorovitch, Dwaipayan Patnaik, Aaron T. Gerds
Journal: Blood
Blood (2024) 144 (Supplement 1): 3804.
https://doi.org/10.1182/blood-2024-205380
Published: 2024
Journal Articles

Estimating Transfusion-Related Medical Costs and Associated Time Burden in Patients with Myelofibrosis: A Comparison of Momelotinib Vs Ruxolitinib Based on Simplify-1

Lucia Masarova, Tom Liu, Mirko Fillbrunn, Weilong Li, Gautam Sajeev, Sumati Rao, Boris Gorsh, James Signorovitch
Journal: Blood
Blood (2023) 142 (Supplement 1): 4571.
https://doi.org/10.1182/blood-2023-181185
Published: 2023
Journal Articles

Retrospective Real-World Analysis of Baseline Characteristics and Posttreatment Hematologic Outcomes in Patients with Myelofibrosis Receiving Ruxolitinib

Andrew T. Kuykendall, Mirko Fillbrunn, Tom Liu, Adina Zhang, Ryan Simpson, Kelesitse Phiri, Gautam Sajeev, James Signorovitch
Journal: Blood
Blood (2023) 142 (Supplement 1): 6399.
https://doi.org/10.1182/blood-2023-181137
Published: 2023
Journal Articles

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel or Other Donor Sources in Patients with Hematologic Malignancies: Comparison of Clinical Trial Results to Center for International Blood and Marrow Transplant Research Database Controls

Smitha Sivaraman, Gautam Sajeev, Yan Song, Chunyi Xu, Chujun He, James E. Signorovitch, Heayoung Shin, Rocio Manghani, Xiao-Ying Tang, Mei-Je Zhang, Linda J Burns, Ronit Simantov
Journal: Blood
Blood (2022) 140 (Supplement 1): 660–661.
https://doi.org/10.1182/blood-2022-162439
Published: 2022
Journal Articles

Bay 81-8973 Prophylaxis Frequency and Long-Term Bleed Outcomes in the Leopold I Extension Study

Kapil Saxena, MD MS, Gautam Sajeev, ScD, Rajeev Ayyagari, PhD, Akanksha Dua, BA, Nikki Church, MD MBA, Martin Sanabria, MD, Olubunmi O. Afonja, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1076.
https://doi.org/10.1182/blood.V130.Suppl_1.1076.1076
Published: 2017
Journal Articles

Patterns of Prior Treatment and Bleeds Among Patients with Severe Hemophilia a: Impact on Frequency of Dosing with Bay 81-8973 in the Leopold I Trial

Nikki Church, MD MBA, Rajeev Ayyagari, PhD, Jennifer Pocoski, PharmD, Gautam Sajeev, ScD, Sneha S Kelkar, MPH, Ella X Du, MS, Monika Mass-Enriquez, MD, Jipan Xie, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1103.
https://doi.org/10.1182/blood.V126.23.1103.1103
Published: 2015